THE PROJECT ALS MISSION
Project ALS identifies and funds the most promising scientific research that will lead to the first effective treatments and a cure for ALS. We recruit the world’s best scientists and doctors to work together—rationally and aggressively—to develop a better understanding of the ALS disease process and, in parallel, better therapeutic strategies.
Project ALS is the world’s first ALS organization to focus exclusively on research. We have raised over $110 million in 23 years to fund ALS research programs at leading academic institutions including Harvard University, Columbia University, UCSF, and the Salk Institute, and have made significant progress toward a cure for ALS.
Read about the latest updates and breakthroughs in ALS research, and see the Project ALS research philosophy – something we’re proud to say has accelerated the pace of research.
FEBRUARY 4, 2021
FREE TO REGISTER
The core of THE CORE—its primary drug assessment platform—is the Kirchhoff Family Drug Screening Unit, where CORE researchers develop new cellular models of ALS, and
The current issue of Neuroscience journal is dedicated to the staggering contributions to science made by longtime Project ALS Research Advisory Board Chair Thomas M.
When Project ALS decided to move prosetin to clinical trial independently, we were newcomers to drug development. Our first task: assembling a team of experts
Project ALS, along with the rest of the world, has faced serious headwinds this year—but we regrouped, focused our priorities, and have taken significant strides